No Race Difference in Prostate Cancer With Equal Access No Race Difference in Prostate Cancer With Equal Access
Black men with nonmetastatic prostate cancer did not appear more likely to die from this disease than white men when given similar access to care and standardized treatment, an analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First Mesothelioma Treatment in 15 Years FDA Approves First Mesothelioma Treatment in 15 Years
The NovoTTF-100L System is approved for use in combination with pemetrexed plus platinum-based chemotherapy in patients with malignant pleural mesothelioma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

AI Beats Radiologists for Accuracy in Lung Cancer Screening AI Beats Radiologists for Accuracy in Lung Cancer Screening
A deep-learning algorithm detected fewer false positives and negatives when screening for lung cancer with low-dose computed tomography (LDCT) scans.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 23, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Your First ASCO: Remember, the Goal Is to Feel Inspired Your First ASCO: Remember, the Goal Is to Feel Inspired
Junior faculty oncologist Bishal Gyawali talks about how first-time ASCO attendees can make the most of their experience.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 22, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Cancer Now Accounts for 1 in 3 Deaths; Prevention Is Key Cancer Now Accounts for 1 in 3 Deaths; Prevention Is Key
Cancer is now the leading cause of death in Canada, and abdominal adiposity is set to become the second leading preventable cause of cancer by 2042.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 22, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Body Adiposity, Not BMI, Key to CV Risk in Colorectal Cancer Body Adiposity, Not BMI, Key to CV Risk in Colorectal Cancer
"One of the exciting developments is there are now automated techniques that can precisely quantify the amount of muscle and fat from CT images." — Justin Brown, Pennington Biomedical Research Center.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 21, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

What's Happening at ASCO 2019? What's Happening at ASCO 2019?
The largest meeting in the oncology world is taking place in Chicago yet again, but this year some novel topics are in the spotlight, as well as the usual clinical data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 21, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lenalidomide Delays Onset of Multiple Myeloma Lenalidomide Delays Onset of Multiple Myeloma
In patients with both high-risk and intermediate smoldering myeloma, treatment with single-agent lenalidomide significantly delayed progression to full-blown disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Now Evidence Supports Reducing Chemo in Frail Elderly Patients Now Evidence Supports Reducing Chemo in Frail Elderly Patients
A lower dose of chemotherapy produced comparable outcomes in elderly patients with advanced gastroesophageal cancer but with lower toxicity and better quality of life.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Dalteparin (Fragmin), First Anticoagulant for Pediatric VTE FDA OKs Dalteparin (Fragmin), First Anticoagulant for Pediatric VTE
The low-molecular-weight heparin is indicated to reduce the recurrence of symptomatic venous thromboembolism in children as young as 1 month.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2019 Category: Cancer & Oncology Tags: Cardiology News Alert Source Type: news

' Striking' Responses in Pediatric Solid Tumors With Entrectinib'Striking' Responses in Pediatric Solid Tumors With Entrectinib
A novel targeted therapy produced impressive responses among children and adolescents with rare tumors that had progressed or were refractory to previous therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How to Avoid ASCO's'Weird,'' Wall Street' Feel How to Avoid ASCO's'Weird,'' Wall Street' Feel
Current ASCO meetings, although fantastic, make Dr Kerr nostalgic for early meetings when he'was a kid'and didn't feel'lost in a vast crowd. 'Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Dense Breast' Proposal Would Lead to Unnecessary Worry and Tests'Dense Breast' Proposal Would Lead to Unnecessary Worry and Tests
The FDA's recent proposal that all women and their referring physicians should receive a breast density report after each mammogram will lead to unnecessary tests and worry, warn experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Okays Another Immunotherapy Plus TKI for Advanced RCC FDA Okays Another Immunotherapy Plus TKI for Advanced RCC
The FDA has approved avelumab in combination with the tyrosine kinase inhibitor (TKI) axitinib for the first-line treatment of advanced renal cell carcinoma (RCC).FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Peak Fitness Lowers Lung, Colorectal Cancer Risk Peak Fitness Lowers Lung, Colorectal Cancer Risk
All-cause mortality reduced in patients who are most fit prior to cancer diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 14, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Can Whole-Body MRI Improve Cancer Staging? Can Whole-Body MRI Improve Cancer Staging?
Two new studies report that whole-body MRI can streamline cancer staging and cut costs, but there are a few caveats.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First Biomarker-Driven Drug for HCC FDA Approves First Biomarker-Driven Drug for HCC
Ramucirumab is for the treatment of hepatocellular carcinoma in patients with an alpha-fetoprotein level of 400 ng/mL or higher.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Diabetes Tied to Cancer Risk in China, With Gender Differences Diabetes Tied to Cancer Risk in China, With Gender Differences
"We suggest that establishing strategies for regular cancer-specific screening and prevention care among patients with [type 2 diabetes] are necessary," the authors conclude.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2019 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

New Entry in'Burgeoning Field' of Prostate Cancer Therapy New Entry in'Burgeoning Field' of Prostate Cancer Therapy
Magnetic resonance-guided transurethral ultrasound ablation is an ablative technology for prostate cancer that destroys nearly the whole gland but leaves urinary function intact.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 10, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Trexit: A'Clean Break' from Transrectal Prostate Biopsies Trexit: A'Clean Break' from Transrectal Prostate Biopsies
Unlike Brexit, Trexit is happening in a timely manner. In the UK, urologists are moving away from transrectal needle biopsies and taking up a transperineal approach, which has less risk for sepsis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Wake-up Call: Global Demand for Chemo Will Double by 2040 Wake-up Call: Global Demand for Chemo Will Double by 2040
In the near future, countries around the world will face serious problems in their ability to deliver chemotherapy to cancer patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Med Student'Influencers' No Different From MDs on Pharma Payroll Med Student'Influencers' No Different From MDs on Pharma Payroll
There is hypocrisy behind the backlash against medical students who make money from their social media influence, argues Vinay Prasad.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Changing Patterns of HPV Oral Cancer in US White Men Changing Patterns of HPV Oral Cancer in US White Men
Incidence rates are slowing in younger white men, while they are rapidly increasing in those aged 60 years and older.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

High-Dose Radiotherapy Boosts Survival Rate in Mesothelioma High-Dose Radiotherapy Boosts Survival Rate in Mesothelioma
Patients who underwent nonradical surgery and received high doses of radiotherapy were twice as likely to be alive at 2 years compared to those who received palliative radiotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Program Fails to Spur More Use of Generic Cancer Drugs Program Fails to Spur More Use of Generic Cancer Drugs
UnitedHealthcare sought to spur greater use of generic cancer drugs by boosting payments in a test. This effort failed to show increased prescribing of the cheaper medicines.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Outside the Box': Tamoxifen for Bladder Cancer'Outside the Box': Tamoxifen for Bladder Cancer
Widely used in the treatment of breast cancer because of its estrogen-blocking activity, tamoxifen has now been tested for the first time in bladder cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Packing a PUNCH in Prostate Cancer: Chemo & ADT & Surgery Packing a PUNCH in Prostate Cancer: Chemo & ADT & Surgery
Investigators of the Preoperative Use of Neoadjuvant Chemotherapy (PUNCH) trial say that this experimental approach should now be a standard in high-risk, localized disease. An expert rejects the idea.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

In NYC Subway, CyberKnife Prostate Cancer Ads Mislead In NYC Subway, CyberKnife Prostate Cancer Ads Mislead
Direct-to-consumer ads about the radiotherapy create'inaccurate impressions,'according to the results of a consumer survey.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Ice Slush in Kidney Cancer Surgery Is Ineffective Ice Slush in Kidney Cancer Surgery Is Ineffective
A first-of-its-kind clinical trial showed that use of soft ice to cool the kidney during open partial nephrectomy did not improve outcomes at 1 year. It's time to get to forgo the slush, investigators say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Allows Continued Sales of Textured Breast Implants FDA Allows Continued Sales of Textured Breast Implants
US regulators are considering additional steps, including adding a boxed warning, regarding risks of breast implants.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Clinical Trials of New Cancer Drugs'Frequently Flawed'Clinical Trials of New Cancer Drugs'Frequently Flawed '
Many randomized clinical trials that lead to approvals for cancer drugs have suboptimal control arms, biasing outcomes in favor of the experimental arm.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Time to Update & quot;Routine, Repeated & quot; Use of Bone Metastasis Drugs Time to Update & quot;Routine, Repeated & quot; Use of Bone Metastasis Drugs
Dr Mark Kris discusses the use of zoledronic acid and denosumab for preventing problems brought on by bone metastases.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Whitish Patch': Increase in Oral Dysplasia in Young Adults'Whitish Patch': Increase in Oral Dysplasia in Young Adults
Dentists report seeing a'most concerning'increase in asymptomatic young adults who have high-grade precancers and no known risk factors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Laser Ablation for Prostate Cancer: Largest Data Set Laser Ablation for Prostate Cancer: Largest Data Set
Focal laser ablation destroys tumor tissue with precision, but nearly 20% of men needed some form of re-treatment after 1 year.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Consensus Reached in Radioactive Iodine, Thyroid Cancer Debate Consensus Reached in Radioactive Iodine, Thyroid Cancer Debate
Thyroid and nuclear medicine societies come to agreement following Martinique summit, produce key"principles" for radioactive iodine use in differentiated thyroid cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2019 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

' Inhumane': Prior Authorization Puts Cancer Patients at Risk'Inhumane': Prior Authorization Puts Cancer Patients at Risk
Bureaucratic foot-dragging jeopardizes patient care, leading to treatment de-lays, financial uncertainty, and sometimes, death.'It is inhumane,'says one radiation oncologist.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Early Aggressive Treatment Urged for Metastatic Prostate Cancer Early Aggressive Treatment Urged for Metastatic Prostate Cancer
Early initiation of life-prolonging therapy is urged in patients with metastatic hormone-sensitive prostate cancer who have disease with high-risk features.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Drug Recyclers Chosen for FDA Pilot Cancer Drug Recyclers Chosen for FDA Pilot
The Food and Drug Administration chose two small start-ups, which take unused oral chemotherapies and give them to patients who cannot afford them, to participate in a new pilot project.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer is Especially Dangerous for Immigrants in South Texas Cancer is Especially Dangerous for Immigrants in South Texas
There are no public hospitals in the Rio Grande Valley counties of Cameron and Hidalgo, meaning uninsured adults who develop cancer have nearly no access to affordable medical care.Kaiser Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Added Convenience of Classifying Nodules With ThyroSeq Test? Added Convenience of Classifying Nodules With ThyroSeq Test?
Nearly equivalent thyroid nodule classifier test success seen when molecular testing performed on cytology smears, compared with samples collected into preserved solution, although results take longer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2019 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

EU Panel Recommends Hydroxycarbamide for Sickle Cell Disease EU Panel Recommends Hydroxycarbamide for Sickle Cell Disease
An EMA committee recommended marketing authorization for hydroxycarbamide for the prevention of vaso-occlusive complications of sickle cell disease in patients older than 2 years.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

' Pendulum Has Swung Too Far' in Opioid Limits for Cancer Pain'Pendulum Has Swung Too Far' in Opioid Limits for Cancer Pain
Dr Kathy Miller discusses the impact of the opioid epidemic on patients with metastatic disease.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Six Factors Tied to DCIS Returning as Breast Cancer Six Factors Tied to DCIS Returning as Breast Cancer
A group of six factors are associated with ductal carcinoma in situ returning as invasive breast cancer after treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New CMS Hospital Rule Seeks More Pay for CAR-T, Some Devices New CMS Hospital Rule Seeks More Pay for CAR-T, Some Devices
CMS has proposed Medicare changes to its add-on payments for innovative medical products as part of its draft fiscal 2020 hospital inpatient rule.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2019 Category: Cancer & Oncology Tags: Hospital Medicine News Source Type: news

For Rare, Difficult Cancer, New Drug Is a'Major Advance'For Rare, Difficult Cancer, New Drug Is a'Major Advance '
Tagraxofusp, the first-ever drug for blastic plasmacytoid dendritic-cell neoplasm, is being called a major advance. Data are now published in the New England Journal of Medicine.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How Do Oncologist Salaries Compare With Other Specialties? How Do Oncologist Salaries Compare With Other Specialties?
Oncologists'salaries in 2018 were in the top half of those reported by all specialties, and about half of those who responded felt that they were being fairly compensated.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Do You Talk to Your Patients About Advance Care Planning? Do You Talk to Your Patients About Advance Care Planning?
A new report found that less than 3% of physicians are using ACP codes for Medicare beneficiaries.Medscape Reader Polls (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Stem Cell Transplant An Effective Tool in Autoimmune Disease Stem Cell Transplant An Effective Tool in Autoimmune Disease
Patients with severe and refractory autoimmune disease such as multiple sclerosis can have marked improvements with hematopoietic stem cell transplant, as long as they are well selected, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Moderate Intake of Red Meat Tied to Higher Colorectal Cancer Risk Moderate Intake of Red Meat Tied to Higher Colorectal Cancer Risk
Consuming moderate amounts of red meat and processed meat is associated with an increased relative risk for colorectal cancer, but eating fiber from bread and cereal may reduce the risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Triple Therapy May Lengthen Survival in Biliary Tract Cancers Triple Therapy May Lengthen Survival in Biliary Tract Cancers
Phase 2 findings suggest nab-paclitaxel plus gemcitabine-cisplatin may prolong survival in advanced biliary tract cancers. However, experts urge caution until a phase 3 trial is completed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news